Calcific Uremic Arteriolopathy Market colloquially known as calciphylaxis, is a rare and life-threatening vascular calcification syndrome. Historically underserved, the market for CUA treatments is currently experiencing a transition toward targeted pharmacological interventions as diagnostic accuracy improves and the global dialysis population expands. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/